CIPLA

Cipla Limited: Basic Information

Full Name: Cipla Limited
Type: Public Sector Pharmaceutical Company
Headquarters: Mumbai, Maharashtra, India
Founded: 1935
Founder: Khwaja Abdul Hamied
Chairman: YK Hamied (as of 2025)
CEO & MD: Umang Vohra (as of 2025)
Tagline: Caring for Life
Industry: Pharmaceuticals and Healthcare

Products and Services:

  • Therapeutic Areas: Respiratory, cardiovascular, oncology, and anti-infectives
  • Generic Drugs: High-quality and affordable medicines
  • Specialty Products: Biologics, inhalation therapy, and critical care drugs
  • Consumer Healthcare: Over-the-counter (OTC) products and wellness solutions

Key Financial Metrics (as of 2024):

  • Revenue: ₹26,000 crore (approx.)
  • Net Profit: ₹4,000 crore (approx.)
  • Market Capitalization: ₹90,000 crore (approx.)

Global Presence:

  • Operations in over 80 countries
  • Manufacturing facilities in India, South Africa, and North America
  • Strong export portfolio, serving key markets like the US, Europe, and Africa

Recognition:

  • Pioneer in making medicines affordable globally
  • Known for innovations in inhalation therapy and biosimilars
  • Recognized for its sustainability initiatives and ethical practices

Cipla Limited is a leading pharmaceutical company committed to providing affordable and high-quality healthcare solutions. Established in 1935 and headquartered in Mumbai, Cipla has been at the forefront of the global fight against life-threatening diseases with its wide range of therapeutic products. The company is a pioneer in respiratory care, oncology, and anti-infectives, offering both generic and specialty medicines. With state-of-the-art manufacturing facilities and a robust R&D pipeline, Cipla caters to millions of patients across more than 80 countries.

Similar to Reliance’s impact on energy and telecom, Cipla has revolutionized the healthcare industry by making life-saving drugs accessible and affordable worldwide. Its focus on innovation, patient-centric solutions, and sustainability underscores its commitment to improving lives. As a trusted name in pharmaceuticals, Cipla continues to lead the way in addressing global healthcare challenges with cutting-edge therapies and a compassionate approach.

Back To Top